Press Releases Archives

VirTrial Announces Service for Virtual Site Monitoring Visits to Allow CRA’s Continued Access to Research Sites During COVID-19 Pandemic

by VirTrial | May 26, 2020 | Press Releases

Scottsdale, AZ (May 26, 2020) – VirTrial today announced a new service designed to enable virtual site monitoring visits in the clinical trials industry. The solution enables pharmaceutical sponsors and CROs to evaluate, qualify and routinely monitor research...

VirTrial Expands Internationally with a Fully Scalable Global Telemedicine Platform and a 31 Country Network of Virtual Trial Capable Research Sites

by VirTrial | Feb 4, 2020 | Press Releases

Scottsdale, AZ (February 4, 2020) – VirTrial today announced its international expansion with a newly appointed International Director of Business Development, a network of virtual trial capable research sites across 31 countries, policies supporting GDPR...

VirTrial Wins Digital Health Solutions Category in the Fierce Innovation Awards – LifeSciences Edition 2019

by VirTrial | Jan 10, 2020 | Press Releases

Scottsdale, AZ (January 9, 2020) – VirTrial announced today that it has been selected as a winner in this year’s Fierce Innovation Awards – LifeSciences Edition, a peer reviewed awards program from the publisher of FierceBiotech and FiercePharma. The competition...

VirTrial Acquires SnapMD and Bolsters Virtual Care Management Platform

by VirTrial | Dec 12, 2019 | Press Releases

Scottsdale, AZ (December 12, 2019) – VirTrial, a portfolio company of Kinderhook Industries, LLC, announced today the acquisition of SnapMD, an industry-leading provider of telemedicine tools and services that improve patient engagement. The acquisition bolsters...

Pratia Teams with VirTrial to Become First ‘Virtual Trial Capable’ Site Network in Europe

by VirTrial | Oct 10, 2019 | Press Releases

Scottsdale, AZ (October 10, 2019) – VirTrial today announced an alliance with Pratia, the largest network of clinical research centers in Europe. All Pratia research centers have completed VirTrial’s Virtual Trial Capable training, making them the first site...

VirTrial Awarded FDA-Approved Decentralized Clinical Trial with Hope Biosciences

by VirTrial | Oct 9, 2019 | Press Releases

Scottsdale, AZ (October 9, 2019) – VirTrial has been awarded an FDA-approved hybrid decentralized clinical trial (DCT) with Hope Biosciences. The study provides Hope Biosciences’ autologous, adipose-derived culture-expanded mesenchymal stem cells (HB-adMSC’s)...

VirTrial Announces Service for Virtual Site Monitoring Visits to Allow CRA’s Continued Access to Research Sites During COVID-19 Pandemic

VirTrial Expands Internationally with a Fully Scalable Global Telemedicine Platform and a 31 Country Network of Virtual Trial Capable Research Sites

VirTrial Wins Digital Health Solutions Category in the Fierce Innovation Awards – LifeSciences Edition 2019

VirTrial Acquires SnapMD and Bolsters Virtual Care Management Platform

Pratia Teams with VirTrial to Become First ‘Virtual Trial Capable’ Site Network in Europe

VirTrial Awarded FDA-Approved Decentralized Clinical Trial with Hope Biosciences

Categories

Recent Posts

Archives